Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-18-058931

President and CSO acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Tepper Mark · President and CSO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-11-14 Exercise or conversion : show line 1 in the form +10,000 $1.00 $10,000 2,110,400 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-11-14 Exercise or conversion : show line 2 in the form Option to purchase common stock −10,000 $1.00 2024-04-11 10,000 261,600 D
Loading xslF345X03/doc4.xml…